Surgical Business Grows: Alcon’s Surgical business continues to gain from the company’s diverse portfolio and incremental innovation. ALC’s flagship lenses, Vivity and PanOptix, continue to lead the ...

The first step to finding a better price for contact lenses is to find an affordable vision exam to get your prescription.

Alcon's core business revolves around eye care products, with a significant presence in the implantables market. The company's portfolio includes intraocular lenses (IOLs), surgical equipment ...

Johnson & Johnson (NYSE: JNJ) expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses ...

A potential sale of Bausch + Lomb presents a significant opportunity for Bausch Health. The deal could provide the company ...

Polyquad was formulated in the mid 1980s by Alcon as a preservative for contact lens storage solutions. It was developed because other preservatives (e.g., BAK) were known to become concentrated ...

Additionally, Alcon is preparing to introduce several other new products that are anticipated to be margin accretive in the long term. This includes the novel 1-week contact lens Precision-7 ...

Investors who lost patience in Bausch Health (BHC) at below $6.00 this past summer missed out. Last week, rumors circulated that Bausch & Lomb (BLCO) is considering a buyout. Lenders have concerns ...

Intraocular lens choice, as facilitated by the surgeon, can connect the patient with the appropriate device for their ...

However, stringent regulations poses a challenge. Key market players include Alcon Inc., Appenzeller Kontaktlinsen AG, Art Optical Contact Lens Inc., Bausch Health Co. Inc., BenQ Materials Corp ...

Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a ...